Año: 2021
Journal Impact Factor (JIF): 4.7570
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | SCIE | 87/279 | Q2 | T1 | D4 |
| BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | 121/297 | Q2 | T2 | D5 |
| MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | 62/139 | Q2 | T2 | D5 |
Año: 2021
Journal Citation Indicator (JCI): 0,810
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | 111/322 | Q2 | T2 | D4 | 65,68 |
| MEDICINE, RESEARCH & EXPERIMENTAL | 72/195 | Q2 | T2 | D4 | 63,33 |
| PHARMACOLOGY & PHARMACY | 133/361 | Q2 | T2 | D4 | 63,30 |
Año:
2021
CiteScore:
3,000
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Medicine (miscellaneous) | 132/276 | Q2 | T2 | D5 |
| Biochemistry, Genetics and Molecular Biology (all) | 104/204 | Q3 | T2 | D6 |
SJR año:
2021
Factor de Impacto:
0,874
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Medicine (miscellaneous) | 582/2548 | Q1 | T1 | D3 |
| Biochemistry, Genetics and Molecular Biology (miscellaneous) | 69/308 | Q2 | T1 | D3 |
| Agencia | Código de Proyecto |
|---|---|
| European Regional Development Fund (University of Salamanca, Spain) | SA264P18-UIC076 |
| Institute of Health Carlos III (CIBERNED) | CB/05/0037 |
| Institute of Health Carlos III (CIBERONC) | CB16/12/00352 |
| Regional Government of Castile and Leon | - |
| Samuel-Solorzano Barruso Foundation (University of Salamanca, Spain) | FS/32-2020 |
| Valdecilla Research Institute (IDIVAL, Santander Spain) | - |
| # | Autor |
|---|---|
| 1 | |
| 2 | Berciano, MT |
| 3 | Santos, E |
| 4 | Lafarga, M |